Johns Hopkins Medicine researchers report that a program designed to enhance self-care and lead to more seamless management of chronic obstructive pulmonary disease (COPD) in adults successfully reduced rates of emergency room visits and hospitalization, and the burdensome symptoms and limitations caused by the condition.
Compared with placebo, a single injection of platelet-rich plasma (PRP) may reduce signs of photoaging as perceived by recipients of the treatment, researchers say. Dr. Murad Alam of Northwestern University in Chicago and colleagues studied 19 patients (mean age, 46; 17 women) with bilateral cheek rhytids of Glogau class II or greater who received a 3 mL injection of PRP in one cheek and normal saline in the other.
In response to the opioid crisis, all 50 states have changed their laws to make naloxone, the overdose reversal drug, easier to get and use. Many states have issued standing medication orders so pharmacists can dispense the life-saving antidote without a prescription.
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led by School of Medicine researchers that tracked patient survival and disease progression.
One day, MRI brain scans may help predict whether older people will develop dementia, new research suggests. In a small study, MRI brain scans predicted with 89 percent accuracy who would go on to develop dementia within three years, according to research at Washington University School of Medicine in St. Louis and the University of California San Francisco
Monitoring cancer can often be an intrusive and exhausting process for patients. But with Brigham Young University chemistry professor Ryan Kelly's new research, there is hope for a simpler way: No more biopsies.
A Phase I/II study, led by investigators at The University of Texas MD Anderson Cancer Center, reports an investigational drug called tagraxofusp has demonstrated high response rates in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare but highly aggressive—and often fatal bone marrow and blood disorder—for which there are no existing approved therapies.
How does individual develop cells choose and commit to their "identity" to become, for example, an immune cell, or a muscle cell, or a neuron? T-lymphocytes are cells in the immune system that act as "intelligence agents" they circulate throughout the body, detect threats, and determine what kind of response the immune system should make.
The US Food and Drug Administration (FDA) has approved emapalumab (Gamifant, Novimmune) for the treatment of adult and pediatric (newborn and older) patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent, or progressive disease or intolerance to conventional HLH therapy.
The European Social Policy Network (ESPN), which is funded by the European Commission and managed jointly by LISER, Applica and the European Social Observatory, has just published a Synthesis Report describing the main features of health systems in terms of access to healthcare in 35 European countries.
Taking typical daily annoyances such as a long wait at the doctor's office or a traffic jam on the freeway in stride may help preserve brain health in older adults, while emotional reactions could contribute to declines in cognition, a new study from Oregon State University has found.
For obese patients with type 2 diabetes, metabolic surgery (sleeve gastrectomy and Roux-Y gastric bypass) prolongs life and reduces cardiovascular events compared to best medical therapy, according to a meta-analytic review.